Dr. Gause is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5705 Industry Lane
Suite J
Frederick, MD 21701Phone+1 301-846-6009Fax+1 301-402-0172
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1981 - 1984
- Emory University School of MedicineResidency, Internal Medicine, 1977 - 1979
- Emory University School of MedicineInternship, Transitional Year, 1976 - 1977
- Michigan State University College of Human MedicineClass of 1976
Certifications & Licensure
- MD State Medical License 1991 - 2026
- GA State Medical License 1979 - 1999
Clinical Trials
- Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer Start of enrollment: 1995 Nov 01
- Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors Start of enrollment: 1997 Oct 01
Publications & Presentations
PubMed
- 470 citationsComplete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma.Maurizio Bendandi, Christopher D. Gocke, Carol B. Kobrin, Floyd A. Benko, Lars Sternas
Nature Medicine. 1999-10-01 - 184 citationsVaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular LymphomaStephen J. Schuster, Sattva S. Neelapu, Barry L. Gause, John E. Janik, Franco M. Muggia
Journal of Clinical Oncology. 2011-07-10 - 125 citationsA pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancyDeirdre O'Mahony, John C. Morris, Cate Quinn, Wendy Gao, Wyndham H. Wilson
Clinical Cancer Research. 2007-02-01
Press Mentions
- Frederick National Laboratory for Cancer Research and Georgetown University Launch Research, Education CollaborationFebruary 27th, 2018
Grant Support
- Idiotype VaccinesDivision Of Basic Sciences - Nci2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: